Form 4: iRhythm Technologies Executive Sells Shares for Tax Obligations

Minang Turakhia, EVP, CMO & CSO of iRhythm Technologies, Inc., sold 1,420 shares of common stock at $145.41 per share to cover tax withholding obligations related to Restricted Stock Unit vesting.

Summary

• Minang Turakhia, Executive Vice President, Chief Marketing Officer, and Chief Strategy Officer of iRhythm Technologies, Inc. (IRTC), reported a transaction on July 2, 2025.
• The transaction involved the disposition of 1,420 shares of iRhythm Technologies common stock.
• The shares were sold at a price of $145.41 per share.
• The sale was conducted to cover tax withholding and remittance obligations associated with the vesting of Restricted Stock Units.
• Following this transaction, Minang Turakhia beneficially owns 41,393 shares of iRhythm Technologies common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary sale for tax purposes related to RSU vesting, which is a neutral event. It does not indicate a positive or negative sentiment towards the company's future prospects.

Positives

• The sale was for tax purposes, indicating a non-discretionary transaction rather than a lack of confidence in the company.
• The executive retains a significant beneficial ownership of 41,393 shares, maintaining alignment with shareholder interests.

Negatives

• A reduction in direct insider ownership, even if for tax purposes, slightly decreases the total shares held by a key executive.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing.

Industry Context

This Form 4 filing details a routine insider transaction for tax purposes, which is common across all industries when Restricted Stock Units vest. It does not provide broader insights into iRhythm Technologies' competitive position or industry trends in medical devices or healthcare technology.

Comparison to Industry Standards

• This Form 4 filing is a standard disclosure of an insider stock transaction for tax purposes, which is a common occurrence across publicly traded companies.
• It does not contain information that allows for a direct comparison of iRhythm Technologies' operational or financial results against specific industry benchmarks or competitor performance.

Related Party Transactions

• The transaction involves an insider (Minang Turakhia) selling shares of the issuer (iRhythm Technologies, Inc.), which is a related party transaction. However, it is specifically for tax obligations related to RSU vesting, a standard compensation practice.

Stakeholder Impact

• Shareholders: The sale slightly reduces insider ownership, but the reason (tax obligations) is routine and generally not viewed negatively. The executive retains a substantial stake, maintaining alignment.
• Employees: No direct impact on employees is indicated.
• Customers: No direct impact on customers is indicated.
• Suppliers: No direct impact on suppliers is indicated.
• Creditors: No direct impact on creditors is indicated.

Key Dates

Keywords

iRhythm Technologies, IRTC, Minang Turakhia, Form 4, Insider Trading, Stock Sale, Restricted Stock Units, Tax Withholding, Executive Compensation, Medical Devices, Healthcare Technology